KEMPHARM, INC KMPH Income Statement

Kempharm, inc (KMPH)

Income statement / TTM

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14
Revenue
0	-	0	-	0	-	0	-	-	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Revenue
-	-	-	-	-	-	-	-	-	0	-	-	-	0	0	0	0	0	0	0	0	0	0	0	0
Operating expenses:
Royalty and direct contract acquisition costs
0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of revenue
-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Research and development
13,010	19,415	23,254	32,968	38,653	41,759	40,991	33,954	28,116	20,593	23,020	21,014	21,352	20,472	17,225	17,266	15,046	13,931	15,126	14,051	12,998	11,917	0	0	0
General and administrative
10,223	10,816	12,404	11,783	12,214	12,508	12,158	12,485	12,639	12,773	13,032	12,817	13,530	14,000	13,693	12,741	11,642	8,883	7,894	6,828	4,970	4,527	0	0	0
Severance expense
0	-	-	-	-	-	0	-	-	0	0	-	-	3,010	0	0	0	-	-	-	-	-	-	-	-
Total operating expenses
0	-	0	-	0	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total operating expenses
-	-	-	46,387	-	-	-	46,439	40,755	33,366	36,052	36,841	37,892	37,482	33,928	30,007	26,688	22,814	23,020	20,879	17,968	16,444	0	0	0
Loss from operations
-12,743	-20,337	-25,195	-46,387	-52,503	-55,903	-54,785	-46,439	-40,755	-33,366	-36,052	-36,841	-37,892	-37,482	-33,928	-30,007	-26,688	-22,814	-23,020	-20,879	-17,968	-16,444	0	0	0
Other (expense) income:
Gain on extinguishment of debt
-	-	-	-	-	-	-	-	-	0	-	-	-	-4,740	-4,740	-4,740	-4,740	0	1,900	0	0	-	-	0	-
Interest expense related to amortization of debt issuance costs and discount
1,922	1,656	1,493	1,448	1,533	1,618	1,496	1,561	1,561	1,561	1,562	1,561	1,564	1,616	1,700	1,789	1,873	1,908	1,911	1,909	1,591	1,114	0	0	0
Interest expense on principal
4,889	4,858	4,910	5,069	5,256	5,469	5,672	5,753	5,777	5,776	5,777	5,770	5,802	5,511	4,764	4,010	3,189	2,671	2,604	2,090	2,140	1,604	0	0	0
Fair value adjustment related to derivative and warrant liability
-1,620	-1,998	-7,470	-10,587	-16,170	-5,976	421	3,577	5,616	3,091	-342	2,269	-14,971	-32,465	-28,978	-28,188	15,236	27,276	29,733	29,833	8,742	7,222	0	0	0
Interest and other (expense) income, net
0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest and other income, net
-	-	425	417	-	420	387	489	379	365	277	221	352	353	359	272	133	31	20	12	0	0	0	-	-
Total other (expense) income
-5,256	-4,207	1,494	4,489	9,839	-689	-7,202	-10,402	-12,575	-10,063	-6,720	-9,379	7,957	20,951	18,133	17,921	-24,905	-31,824	-34,228	-33,820	-10,566	-8,033	0	0	0
Loss before income taxes
-17,999	-24,544	-23,701	-41,898	-42,664	-56,592	-61,987	-56,841	-53,330	-43,429	-42,772	-46,220	-29,935	-16,531	-15,795	-12,086	-51,593	-54,638	-57,248	-54,699	-28,534	-24,477	0	0	0
Income tax benefit
-	-22	-33	-96	-126	-126	-138	-82	-47	-43	-16	-31	-31	-15	-12	27	31	26	54	-4	-10	-22	0	0	0
Net loss
-17,985	-24,522	-23,668	-41,802	-42,538	-56,466	-61,849	-56,759	-53,283	-43,386	-42,756	-46,189	-29,904	-16,516	-15,783	-12,113	-51,624	-54,664	-57,302	-54,695	-28,524	-24,455	0	0	0
Net loss per share of common stock:
Basic and diluted (in dollars per share)
-0.12	-	-	-	-0.46	-	-	-	-1.77	-	-0.68	-	-1.11	-	-	-	-	-	-	-	-	-4.97	-3.00	-1.50	-0.80
Basic (in dollars per share)
-	-	0.09	-0.33	-	-	-0.94	-0.65	-	-	-	-0.44	-	-	-	-	-	-	-	-	-	-	-	-	-
Diluted (in dollars per share)
-	-	0.06	-0.33	-	-	-0.94	-0.91	-	-	-	-0.44	-	-	-	-	-	-	-	-	-	-	-	-	-
Weighted average number of shares of common stock outstanding:
Basic and diluted (in shares)
48,073	-	-	-	26,701	-	-	-	14,791	-	14,657	-	14,646	-	-	-	-	-	-	-	-	-	-	-	-
Basic (in shares)
-	-	30,126	28,386	-	-	16,033	15,317	-	-	-	14,649	-	-	-	-	-	-	-	-	-	-	-	-	-
Diluted (in shares)
-	-	31,672	28,386	-	-	16,033	16,548	-	-	-	14,649	-	-	-	-	-	-	-	-	-	-	-	-	-